Sample-to-Answer Assays and Automation for Gastrointestinal Testing
Gastroenterology
Diseases and disorders of the gastrointestinal tract often have a significant impact on quality of life. Overlapping symptoms make it difficult to differentiate between cancers, inflammatory diseases and functional disorders. The growing range of molecular and immunodiagnostic tests detecting GI pathogens, protein biomarkers, and antibody-mediated immune response is accelerating diagnosis and treatment.
In an effort to improve patient care, an increasing number of gastroenterologists are using fecal calprotectin levels as a first step in the diagnosis of IBD versus IBS. ALPCO tests enable clinicians to accurately assess patients via calprotectin and quickly start patients on the right treatment path.
ALPCO offers targeted GI solutions suitable for all types of labs. Our offerings range from plate-based to clinical chemistry analyzer-based and automated flash chemiluminescence solutions, all designed to accommodate your lab’s expanding testing needs and capabilities.
In the webinar, Dr. Benjamin Click from the University of Colorado, Department of Gastroenterology, underscores the critical role of non-invasive monitoring methods, particularly fecal calprotectin monitoring, in guiding treatment adjustments and achieving therapeutic goals..
This infographic distills the essence of the new American Gastroenterological Association (AGA) Clinical Practice Guideline on the Role of Biomarkers in Crohn's Disease (CD). It sheds light on the nuanced recommendations for using biomarkers to monitor and evaluate CD, emphasizing their value in...